Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             112 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Author index 1997
 5 S1 p. S47-S49
3 p.
 artikel
2 L2.14 Activation of penile nerves by nicotinic agonists 1997
 5 S1 p. S17-
1 p.
 artikel
3 L2.5 Acute and chronic effects of nicotine on cerebral dopamine 1997
 5 S1 p. S13-
1 p.
 artikel
4 L3.11 Approaches to design transition state analogs 1997
 5 S1 p. S23-
1 p.
 artikel
5 L2.7 Behavioral effects of nicotine: Focus on reward and social behavior; interactions with calcium antagonists 1997
 5 S1 p. S14-
1 p.
 artikel
6 L2.6 Behavioral sensitization to nicotine 1997
 5 S1 p. S13-
1 p.
 artikel
7 L3.9 Binding-site studies at dopamine D2 and serotonin 5-HT1A receptors 1997
 5 S1 p. S22-
1 p.
 artikel
8 L3.7 Bioinformatics in drug discovery: Examples and prospects 1997
 5 S1 p. S21-
1 p.
 artikel
9 L2.12 Cholinergic and non-cholinergic regulation of gene expression in adrenal medulla 1997
 5 S1 p. S16-
1 p.
 artikel
10 L3.6 Combinatorial chemistry: The fine art of solid phase synthesis 1997
 5 S1 p. S20-
1 p.
 artikel
11 L2.13 Cotinine-nicotine interactions 1997
 5 S1 p. S17-
1 p.
 artikel
12 L3.5 Design of drugs through a consideration of drug metabolism and pharmacokinetics 1997
 5 S1 p. S20-
1 p.
 artikel
13 L2.9 Epibatidine: Utility for probing nicotinic receptor pharmacology and regulation 1997
 5 S1 p. S15-
1 p.
 artikel
14 L2.2 Formation of nicotinic synapses at the neuromuscular junction 1997
 5 S1 p. S11-
1 p.
 artikel
15 L2.1 Functional aspects of nicotinic receptors: Native and recombinant 1997
 5 S1 p. S11-
1 p.
 artikel
16 L3.4 Human cell lines for the investigation of drug metabolism 1997
 5 S1 p. S19-
1 p.
 artikel
17 L1.3 Hydrogels for controlled oral drug delivery 1997
 5 S1 p. S7-
1 p.
 artikel
18 L1.8 Improving properties for direct compression 1997
 5 S1 p. S9-
1 p.
 artikel
19 L3.3 In vitro approaches to predict cypcatalyzed drug metabolism and drug interactions in man in development of pharmaceuticals 1997
 5 S1 p. S19-
1 p.
 artikel
20 L1.5 Is there a need for time-controlled dosage forms 1997
 5 S1 p. S8-
1 p.
 artikel
21 L1.2 Knowledge-based systems in formulation and process development 1997
 5 S1 p. S6-
1 p.
 artikel
22 L3.2 Metabolic engineering: A novel approach to the improvement of secondary metabolite production in plants or plant cell cultures 1997
 5 S1 p. S18-
1 p.
 artikel
23 L3.10 Molecular modelling of H3 agonists and antagonists 1997
 5 S1 p. S22-
1 p.
 artikel
24 L1.9 Multifunctional excipients for direct compression of tablets 1997
 5 S1 p. S10-
1 p.
 artikel
25 L3.1 Natural products from higher plants as leads for drug development 1997
 5 S1 p. S18-
1 p.
 artikel
26 L2.8 Neuroprotective and therapeutic actions of nicotine 1997
 5 S1 p. S14-
1 p.
 artikel
27 L1.10 New formulations of methacrylate copolymers for improved coating technology 1997
 5 S1 p. S10-
1 p.
 artikel
28 L2.10 Novel ligands of nicotinic receptors 1997
 5 S1 p. S15-
1 p.
 artikel
29 L1.1 Optimisation of pharmaceutical formulations 1997
 5 S1 p. S6-
1 p.
 artikel
30 L2.3 Potential roles of nicotinic receptor activation and desensitization in addiction to nicotine 1997
 5 S1 p. S12-
1 p.
 artikel
31 L3.8 Protein modelling in drug discovery 1997
 5 S1 p. S21-
1 p.
 artikel
32 L2.4 Studies of nicotinic receptors in human brain diseases 1997
 5 S1 p. S12-
1 p.
 artikel
33 L2.11 The role of cholinergic muscarinic and nicotinic receptors in the modulation of attention and memory 1997
 5 S1 p. S16-
1 p.
 artikel
34 L1.6 Time-controlled drug release from compression-coated tablet formulations 1997
 5 S1 p. S8-
1 p.
 artikel
35 L1.4 Use of hard gelatin capsules as rectal dosage forms 1997
 5 S1 p. S7-
1 p.
 artikel
36 L1.7 Utilisation of neutron activation and γ-scintigraphy in the development of gastrointestinal dosage forms 1997
 5 S1 p. S9-
1 p.
 artikel
37 O3.1 Catalytic antibodies elicited by a hapten with twisted α-keto amide moiety 1997
 5 S1 p. S26-
1 p.
 artikel
38 O3.4 Comparative molecular field analysis study of phosphodiesterase inhibitors 1997
 5 S1 p. S27-
1 p.
 artikel
39 O3.3 3D QSAR of bile acid reabsorption inhibitors 1997
 5 S1 p. S27-
1 p.
 artikel
40 O1.2 Drug permeation through pH- and thermo-responsive porous polymer membranes 1997
 5 S1 p. S26-
1 p.
 artikel
41 O1.3 Linearity of the pharmacokinetics of a new anxiolytic compound deramciclane in dogs 1997
 5 S1 p. S26-
1 p.
 artikel
42 O3.2 Phenotyping of pulmonary udpglucuronosyltransferase activity in lung cancer surgery patients 1997
 5 S1 p. S27-
1 p.
 artikel
43 O1.1 Spironolactone stability in solutions of β-cyclodextrin derivatives 1997
 5 S1 p. S26-
1 p.
 artikel
44 P3.26 Action of bearberry and pineapple-weed aqueous extracts on Escherichia coli surface structures 1997
 5 S1 p. S46-
1 p.
 artikel
45 P3.12 A GC-MS identification of novel ketamine metabolites 1997
 5 S1 p. S43-
1 p.
 artikel
46 P3.22 Analysis of bio-active flavonoids in extracts of four Epimedium species by micellar electrokinetic capillary chromatography 1997
 5 S1 p. S45-
1 p.
 artikel
47 P1.7 Approaches to design panasorb® new drug form 1997
 5 S1 p. S31-
1 p.
 artikel
48 P2.6 Changes in nicotinic receptor subunit mRNA levels in lymphocytes from normal and alzheimer patients 1997
 5 S1 p. S34-
1 p.
 artikel
49 P1.5 Characterisation of centrifugal granulating process of initial spherical beads based on microcrystalline cellulose 1997
 5 S1 p. S31-
1 p.
 artikel
50 P2.10 Chronic ethanol treatment differently interacts with nicotinic and muscarinic receptor subtypes expressed in M10 and SH-SY5Y neuroblastoma cells 1997
 5 S1 p. S35-
1 p.
 artikel
51 P1.3 Compression behaviour of tolbutamide/hydroxypropyl-β-cyclodextrin inclusion complex 1997
 5 S1 p. S30-
1 p.
 artikel
52 P3.20 Computer assisted HPLC-method development for separation for tropane and opium alkaloids using turbo method development® and dry lab® systems 1997
 5 S1 p. S45-
1 p.
 artikel
53 P3.4 Conformational analysis of three oligosaccharides related to the branch region of multivalent sLex glycans 1997
 5 S1 p. S41-
1 p.
 artikel
54 P2.28 Cyclic AMP signal inactivation in UMR-106 osteosarcoma cells: Role of cAMP-phosphodiesterase and cAMP efflux 1997
 5 S1 p. S39-
1 p.
 artikel
55 P1.11 Cyclodextrins in ophthalmic formulations of dipivefrin 1997
 5 S1 p. S32-
1 p.
 artikel
56 P2.24 Debrisoquin and S-mephenytoin hydroxylation polymorphisms in a Russian population living in Estonia 1997
 5 S1 p. S38-
1 p.
 artikel
57 P2.5 Deficits in neuronal nicotinic receptors in the Swedish 670/671 mutation alzheimer family and sporadic alzheimer cases 1997
 5 S1 p. S34-
1 p.
 artikel
58 P3.9 Determination of entacapone glucuronides by micellar electrokinetic capillary chromatography 1997
 5 S1 p. S42-
1 p.
 artikel
59 P3.21 Development of HPLC methods for flavonoids in biological matrices 1997
 5 S1 p. S45-
1 p.
 artikel
60 P2.8 Diazepam and nicotine gum: Minor interaction on human performance 1997
 5 S1 p. S34-
1 p.
 artikel
61 P2.19 Differential effects of μ- and δ-opioid receptor agonists on locomotor activity of alcohol-preferring AA, alcohol-avoiding ANA and non-selected wistar rats 1997
 5 S1 p. S37-
1 p.
 artikel
62 P2.15 Effect of epibatidine on the extracellular concentrations of dopamine and its metabolites in the nucleus accumbens of conscious rats: A microdialysis study 1997
 5 S1 p. S36-
1 p.
 artikel
63 P2.2 Effects of chronic nicotinic ligand exposure on nicotinic receptors in M10 and neuroblastoma SH-SY5Y cells 1997
 5 S1 p. S33-
1 p.
 artikel
64 P2.17 Effects of repeated morphine administration on mesolimbic dopamine release in alcohol preferring aa and alcohol avoiding ana rats 1997
 5 S1 p. S37-
1 p.
 artikel
65 P2.21 Effects of the neuropeptide Y Y1 receptor antagonist BIBP 3226 on food intake 1997
 5 S1 p. S38-
1 p.
 artikel
66 P3.13 Electrospray ionization mass spectrometry as a useful technique to elucidate the structure of complex ligands for histamine receptors 1997
 5 S1 p. S43-
1 p.
 artikel
67 P1.9 Enteric polymers as binder and coating materials in ibuprofen and furosemide granules 1997
 5 S1 p. S32-
1 p.
 artikel
68 P3.5 Estimation of the aqueous solubility of drugs using artificial neural networks 1997
 5 S1 p. S41-
1 p.
 artikel
69 P1.2 Evaluation of tablet surface homogeneity by computer-generated hologram method 1997
 5 S1 p. S30-
1 p.
 artikel
70 P2.25 Glial cell line -derived neurotrophic factor system in rat penis 1997
 5 S1 p. S39-
1 p.
 artikel
71 P3.8 Glucuronidation of nitrocatecholic COMT inhibitors by rat liver microsomes 1997
 5 S1 p. S42-
1 p.
 artikel
72 P3.2 1H-NMR conformational studies and molecular dynamics of selegiline derivatives 1997
 5 S1 p. S40-
1 p.
 artikel
73 P1.10 Improved aqueous solubility and oral bioavailability of phenytoin by (SBE)7m-β-CD and HP-β-CD complexation 1997
 5 S1 p. S32-
1 p.
 artikel
74 P3.6 Influence of physicochemistry on the brain penetration of the 'triptans in the rat 1997
 5 S1 p. S41-
1 p.
 artikel
75 P2.7 Interaction of galanthamine, NXX-066 and E2020 with neuronal α4β2 nicotinic receptor expressed in M10 cells 1997
 5 S1 p. S34-
1 p.
 artikel
76 P2.20 Involvement of cerebral nor-adrenaline in the morphine-induced locomotor sensitisation in mice 1997
 5 S1 p. S37-
1 p.
 artikel
77 P3.24 Isolation and identification of cyclopentene cyanohydrin bis-glycosides from three Passiflora species 1997
 5 S1 p. S46-
1 p.
 artikel
78 P3.11 Kinetic fluorometric assay for coumarin 7-hydroxylation 1997
 5 S1 p. S42-
1 p.
 artikel
79 P3.10 LC/MS-analysis of some catechol-type glucuronides from urine samples 1997
 5 S1 p. S42-
1 p.
 artikel
80 PL2 Computer assisted determination of sub-type specific pharmacophores for GPCR agonists 1997
 5 S1 p. S3-
1 p.
 artikel
81 PL1 Prediction of intestinal drug absorption in cell cultures: Caco-2 and beyond 1997
 5 S1 p. S2-
1 p.
 artikel
82 P1.8 Modification of drug release with calcium alginate forming ex tempore in hard gelatin capsules 1997
 5 S1 p. S31-
1 p.
 artikel
83 P3.1 Molecular dynamics: Comparison of the MD force fields 1997
 5 S1 p. S40-
1 p.
 artikel
84 P2.26 Neuronal localization of ETB-receptors in the bovine retractor penis muscle 1997
 5 S1 p. S39-
1 p.
 artikel
85 P3.16 New remote heterocyclic structural analogues of phenazone as potential anti-inflammatory drugs 1997
 5 S1 p. S44-
1 p.
 artikel
86 P2.9 Nicotine and cotinine modulate eicosanoid synthesis in vitro 1997
 5 S1 p. S35-
1 p.
 artikel
87 P2.18 Opioid receptor subtype distribution in brains of alcohol-preferring and alcohol-avoiding rats 1997
 5 S1 p. S37-
1 p.
 artikel
88 P2.1 Orphan α5 and α6 subunits form functional nAChRs in human transfected cells 1997
 5 S1 p. S33-
1 p.
 artikel
89 P1.12 Pharmacokinetic evaluation of pulmonary delivered cyclosporin a-DLPC liposomes in mice 1997
 5 S1 p. S32-
1 p.
 artikel
90 P2.27 Pharmacokinetics of different factor VIII preparations in haemophilia a patients 1997
 5 S1 p. S39-
1 p.
 artikel
91 P2.23 Pharmacological comparison of rat ϱ1 ‘GABAC’ receptors with rat hippocampal and crayfish GABAA receptors 1997
 5 S1 p. S38-
1 p.
 artikel
92 P2.22 Pharmacological profiles of cerebellar GABAA receptors in α6 subunit knockout and wild type mice 1997
 5 S1 p. S38-
1 p.
 artikel
93 P3.17 Photodecomposition studies on trichlormethiazide in ethanolic solution 1997
 5 S1 p. S44-
1 p.
 artikel
94 P3.3 Quantum chemical insight into protein phosphorylation 1997
 5 S1 p. S40-
1 p.
 artikel
95 P2.4 Regional distribution of nicotinic receptors in human brain and effects of aging as characterized by [3H]-epibatidine 1997
 5 S1 p. S33-
1 p.
 artikel
96 P2.16 Repeated cocaine treatment sensitises mesolimbic dopamine release and locomotor activity more in alcohol-preferring aa than alcohol-avoiding ana rats 1997
 5 S1 p. S36-
1 p.
 artikel
97 P1.6 Some aspects granulation of a ginseng's extract in fluidized bed 1997
 5 S1 p. S31-
1 p.
 artikel
98 P3.23 Spontaneous somatic embryogenesis and plant regeneration of the medicinal plant Angelica archangelica 1997
 5 S1 p. S45-
1 p.
 artikel
99 P3.7 Structural characterization of E- and Z-entacapone glucuronides 1997
 5 S1 p. S41-
1 p.
 artikel
100 P3.15 Synthesis and anti-inflammatory activity of derivatives of thiazolidine with fragments of hydrazides of carboxylic acids in molecules 1997
 5 S1 p. S43-
1 p.
 artikel
101 P2.11 Systemic nicotine induces fos like immunoreactivity in the nucleus accumbens and medial prefrontal cortex by separate mechanisms 1997
 5 S1 p. S35-
1 p.
 artikel
102 P3.19 The choice of parameters in AMD (automated multiple development) optimization 1997
 5 S1 p. S44-
1 p.
 artikel
103 P2.14 The effect of acute nicotine on dopamine metabolism in striatal and limbic brain areas during chronic nicotine and after 72-h withdrawal 1997
 5 S1 p. S36-
1 p.
 artikel
104 P2.13 The effect of acute nicotine on the expression of fos protein in striatal and limbic brain areas during chronic nicotine and after 72-h withdrawal 1997
 5 S1 p. S36-
1 p.
 artikel
105 P2.12 The effect of nicotine on the expression of fos protein in hypothalamic brain areas and the interpeduncular nucleus of rats during chronic nicotine and after 72-h withdrawal 1997
 5 S1 p. S35-
1 p.
 artikel
106 P1.4 The effects of some formulation and process variables on the properties of direct-compression diazepam tablets 1997
 5 S1 p. S30-
1 p.
 artikel
107 P2.3 The induction and loss of brain nicotine-receptor up-regulation after chronic nicotine in the drinking water to mice 1997
 5 S1 p. S33-
1 p.
 artikel
108 P3.14 The simultaneous determination of clodronate and its partial ester derivatives by ion-pair RP HPLC coupled with evaporative light-scattering detection 1997
 5 S1 p. S43-
1 p.
 artikel
109 P3.18 The X-ray diffraction of some gastrointestinal drugs 1997
 5 S1 p. S44-
1 p.
 artikel
110 P3.25 The X-ray diffractometric determination of some minerals of Hyoscyamus niger 1997
 5 S1 p. S46-
1 p.
 artikel
111 P2.29 Total antioxidant status and oxidative stress in the blood of adriamycin-treated malignant lymphoma patients 1997
 5 S1 p. S40-
1 p.
 artikel
112 P1.1 Validation of sieve analysis system 1997
 5 S1 p. S30-
1 p.
 artikel
                             112 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland